Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity

In the current study, we examined whether the combination of tumor vasculature-targeted gene therapy with adeno-associated virus bacteriophage-tumor necrosis factor-α (AAVP-TNF-α) and/or the orally administered LCL161, an antagonist of inhibitors of apoptosis proteins (IAPs), enhanced antitumor effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Z, Syrkin, G, Adem, A, Geha, R, Pastoriza, J, Vrikshajanani, C, Smith, T, Quinn, T J, Alemu, G, Cho, H, Barrett, C J, Arap, W, Pasqualini, R, Libutti, S K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534156/
https://www.ncbi.nlm.nih.gov/pubmed/23154431
http://dx.doi.org/10.1038/cgt.2012.83

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534156/
https://www.ncbi.nlm.nih.gov/pubmed/23154431
http://dx.doi.org/10.1038/cgt.2012.83

Ejemplares similares